Edition:
United Kingdom

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

7.55USD
7:49pm BST
Change (% chg)

$0.12 (+1.62%)
Prev Close
$7.43
Open
$7.36
Day's High
$7.82
Day's Low
$7.36
Volume
17,641
Avg. Vol
28,171
52-wk High
$11.95
52-wk Low
$4.16

Latest Key Developments (Source: Significant Developments)

Cue Biopharma Announces FDA Acceptance Of Ind For Lead Immuno-Oncology Candidate, Cue-101, In Treatment Of Hpv-Driven Cancers
Thursday, 16 May 2019 

May 16 (Reuters) - Cue Biopharma Inc ::CUE BIOPHARMA ANNOUNCES FDA ACCEPTANCE OF IND FOR LEAD IMMUNO-ONCOLOGY CANDIDATE, CUE-101, IN TREATMENT OF HPV-DRIVEN CANCERS.CUE BIOPHARMA INC - INITIATION OF FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL FOR MONOTHERAPY DOSE ESCALATION.CUE BIOPHARMA INC - EARNS $2.5 MILLION MILESTONE FOR IND ACCEPTANCE FROM PARTNER LG CHEM LIFE SCIENCES.  Full Article

Peter Appel Reports Passive Stake Of 7.6 Pct In Cue Biopharma
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Cue Biopharma Inc ::PETER APPEL REPORTS A PASSIVE STAKE OF 7.6 PERCENT IN CUE BIOPHARMA INC AS OF DEC 27, 2017 - SEC FILING.  Full Article

Mark Strome Reports 5.7 Pct Passive Stake In Cue Biopharma
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Mark Strome::MARK STROME REPORTS A 5.7 PERCENT PASSIVE STAKE IN CUE BIOPHARMA INC AS OF DECEMBER 27, 2017- SEC FILING.  Full Article

Cue Biopharma Announces Closing Of Initial Public Offering
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Cue Biopharma Inc ::CUE BIOPHARMA ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING.  Full Article

Cue Biopharma sees IPO of up to 8 mln shares of its common stock priced at $7.50/shr
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Cue Biopharma Inc ::CUE BIOPHARMA INC SEES IPO OF UP TO 8 MILLION SHARES OF ITS COMMON STOCK PRICED AT $7.50 PER SHARE - SEC FILING.CUE BIOPHARMA INC HAD PREVIOUSLY EXPECTED ITS IPO OF UP TO 8.3 MILLION SHARES OF CO'S COMMON STOCK TO BE PRICED BETWEEN $6.00 AND $8.00 PER SHARE.  Full Article